Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection

Molecular Pain

Volumn 8, Issue , 2012, Pages

  Guida, Francesca ^a   Luongo, Livio ^a   Aviello, Gabriella ^b   Palazzo, Enza ^a   De Chiaro, Maria ^a   Gatta, Luisa ^a   Boccella, Serena ^a   Marabese, Ida ^a   Zjawiony, Jordan K ^c   Capasso, Raffaele ^b   Izzo, Angelo A ^b   de Novellis, Vito ^a   Maione, Sabatino ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Allodynia; Formalin injection; Glial cells; Nociceptive spinal neurons; Salvinorin A

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; CANNABINOID 1 RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; KAPPA OPIATE RECEPTOR; SALVINORIN A;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL POPULATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; EVOKED RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MOUSE; NERVE CELL; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPIKE WAVE; TREATMENT DURATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DITERPENES, CLERODANE; FORMALDEHYDE; HYPERALGESIA; MALE; MICE; MICE, INBRED ICR; NOCICEPTORS; PAIN; SPINAL CORD;

EID: 84865209944     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-8-60     Document Type: Article

References (55)

1. Bonica JJ. Treatment of pain and nerve block. Masui 1970, 19:1-10.
2. Millan MJ. The induction of pain: an integrative review. Prog Neurobiol 1999, 57:1-164. Review, 10.1016/S0301-0082(98)00048-3, 9987804.
3. Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, Inoue K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003, 424:778-783. 10.1038/nature01786, 12917686.
4. Inoue K. ATP receptors of microglia involved in pain. Novartis Found Symp 2006, 276:263-272. discussion, 273-81. Review.
5. McMahon SB, Cafferty WB, Marchand F. Immune and glial cell factors as pain mediators and modulators. Exp Neurol 2005, 192:444-462. Review, 10.1016/j.expneurol.2004.11.001, 15755561.
6. De Leo JA, Tawfik VL, LaCroix-Fralish ML. The tetrapartite synapse: path to CNS sensitization and chronic pain. Pain 2006, 122:17-21. Review, 10.1016/j.pain.2006.02.034, 16564626.
7. Watkins LR, Hutchinson MR, Ledeboer A, Wieseler-Frank J, Milligan ED, Maier SF. Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun 2007, 21:131-146. 10.1016/j.bbi.2006.10.011, 1857294, 17175134.
8. Ji RR, Kawasaki Y, Zhuang ZY, Wen YR, Decosterd I. Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biol 2006, 2:259-269. 10.1017/S1740925X07000403, 1949390, 17710215.
9. Watkins LR, Martin D, Ulrich P, Tracey KJ, Maier SF. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 1997, 71:225-235. 10.1016/S0304-3959(97)03369-1, 9231865.
10. Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 2003, 306:624-630. 10.1124/jpet.103.052407, 12734393.
11. Tanga FY, Raghavendra V, DeLeo JA. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem Int 2004, 45:397-407. 10.1016/j.neuint.2003.06.002, 15145554.
12. Clark AK, Yip PK, Malcangio M. The liberation of fractalkine in the dorsal horn requires microglial cathepsin S. J Neurosci 2009, 29:6945-6954. 10.1523/JNEUROSCI.0828-09.2009, 2698289, 19474321.
13. Luongo L, Palazzo E, Tambaro S, Giordano C, Gatta L, Scafuro MA, Rossi FS, Lazzari P, Pani L, de Novellis V, Malcangio M, Maione S. 1-(2',4'-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice. Neurobiol Dis 2010, 37:177-185. 10.1016/j.nbd.2009.09.021, 19804829.
14. Fu KY, Light AR, Maixner W. Long-lasting inflammation and long-term hyperalgesia after subcutaneous formalin injection into the rat hindpaw. J Pain 2001, 2:2-11. 10.1054/jpai.2001.9804, 14622781.
15. Fu KY, Tan YH, Sung B, Mao J. Peripheral formalin injection induces unique spinal cord microglial phenotypic changes. Neurosci Lett 2009, 449:234-239. 10.1016/j.neulet.2008.11.009, 19015000.
16. Clark AK, Gentry C, Bradbury EJ, McMahon SB, Malcangio M. Role of spinal microglia in rat models of peripheral nerve injury and inflammation. Eur J Pain 2007, 11:223-230. 10.1016/j.ejpain.2006.02.003, 16545974.
17. Lin CS, Tsaur ML, Chen CC, Wang TY, Lin CF, Lai YL, Hsu TC, Pan YY, Yang CH, Cheng JK. Chronic intrathecal infusion of minocycline prevents the development of spinal-nerve ligation-induced pain in rats. Reg Anesth Pain Med 2007, 32:209-216.
18. Eliav E, Herzberg U, Ruda MA, Bennett GJ. Neuropathic pain from an experimental neuritis of the rat sciatic nerve. Pain 1999, 83:169-182. 10.1016/S0304-3959(99)00102-5, 10534588.
19. Wang Z, Gardell LR, Ossipov MH, Vanderah TW, Brennan MB, Hochgeschwender U, Hruby VJ, Malan TP, Lai J, Porreca F. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci 2001, 21:1779-1786.
20. Nozaki-Taguchi N, Yaksh TL. Spinal and peripheral mu opioids and the development of secondary tactile allodynia after thermal injury. Anesth Analg 2002, 94:968-974. 10.1097/00000539-200204000-00036, 11916806.
21. Przewlocki R, Przewlocka B. Opioids in neuropathic pain. Curr Pharm Des 2005, 11:3013-3025. Review, 10.2174/1381612054865055, 16178760.
22. Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984, 7:309-338. 10.1146/annurev.ne.07.030184.001521, 6143527.
23. Ortega A. Salvinorin, a new trans-neoclorodane diterpene from Salvia divinorum (Labiatae). J Chem Soc Perkins Trans 1982, I:2505-2508.
24. Valdés LJ. Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A. J Psychoactive Drugs 1994, 26:277-283. Review, 10.1080/02791072.1994.10472441, 7844657.
25. Gonzàlez D, Riba J, Bouso JC, Gómez-Jarabo G, Barbanoj MJ. Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug Alcohol Depend 2006, 85:157-162. 10.1016/j.drugalcdep.2006.04.001, 16720081.
26. Capasso R, Borrelli F, Capasso F, Siebert DJ, Stewart DJ, Zjawiony JK, Izzo AA. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum. Neurogastroenterol Motil 2006, 18(1):69-75. 10.1111/j.1365-2982.2005.00725.x, 16371085.
27. Capasso R, Borrelli F, Cascio MG, Aviello G, Huben K, Zjawiony JK, Marini P, Romano B, Di Marzo V, Capasso F, Izzo AA. Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors. Br J Pharmacol 2008, 155:681-689. 2584932, 18622408.
28. McCurdy CR, Sufka KJ, Smith GH, Warnick JE, Nieto MJ. Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist. Pharmacol Biochem Behav 2006, 83:109-113. 10.1016/j.pbb.2005.12.011, 16434091.
29. Ansonoff MA, Zhang J, Czyzyk T, Rothman RB, Stewart J, Xu H, Zjwiony J, Siebert DJ, Yang F, Roth BL, Pintar JE. Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice. J Pharmacol Exp Ther 2006, 318(2):641-648. 10.1124/jpet.106.101998, 16672569.
30. Aviello G, Borrelli F, Guida F, Romano B, Lewellyn K, De Chiaro M, Luongo L, Zjawiony JK, Maione S, Izzo AA, Capasso R. Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo. J Mol Med 2011, 89:891-902. 10.1007/s00109-011-0752-4, 21499737.
31. Hains BC, Waxman SG. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci 2006, 26:308-4317.
32. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977, 4:161-174.
33. Coderre TJ, Vaccarino AL, Melzack R. Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res 1990, 535:155-158. 10.1016/0006-8993(90)91835-5, 2292020.
34. Bianchi M, Panerai AE. Formalin injection in the tail facilitates hindpaw withdrawal reflexes induced by thermal stimulation in the rat: effect of paracetamol. Neurosci Lett 1997, 237:89-92. 10.1016/S0304-3940(97)00819-7, 9453222.
35. Cadet R, Aigouy L, Woda A. Enhanced nociceptive behaviour following conditioning injection of formalin in the perioral area of the rat. Brain Res 1995, 676:189-195. 10.1016/0006-8993(95)00055-U, 7796169.
36. Vierck CJ, Yezierski RP, Light AR. Long-lasting hyperalgesia and sympathetic dysregulation after formalin injection into the rat hind paw. Neuroscience 2008, 153:501-506. 10.1016/j.neuroscience.2008.02.027, 18378404.
37. Ambriz-Tututi M, Rocha-González HI, Castañeda-Corral G, Araiza-Saldaña CI, Caram-Salas NL, Cruz SL, Granados-Soto V. Role of opioid receptors in the reduction of formalin-induced secondary allodynia and hyperalgesia in rats. Eur J Pharmacol 2009, 619:25-32. 10.1016/j.ejphar.2009.08.001, 19686723.
38. Capasso R, Borrelli F, Zjawiony J, Kutrzeba L, Aviello G, Sarnelli G, Capasso F, Izzo AA. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice. Neurogastroenterol Motil 2008, 20(2):142-148.
39. Braida D, Capurro V, Zani A, Rubino T, Viganò D, Parolaro D, Sala M. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents. Br J Pharmacol 2009, 157:844-853. 10.1111/j.1476-5381.2009.00230.x, 2721268, 19422370.
40. Walentiny DM, Vann RE, Warner JA, King LS, Seltzman HH, Navarro HA, Twine CE, Thomas BF, Gilliam AF, Gilmour BP, Carroll FI, Wiley JL. Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents. Psychopharmacology 2010, 210:275-284. 10.1007/s00213-010-1827-6, 3013230, 20354680.
41. Valverde O, Ledent C, Beslot F, Parmentier M, Roques BP. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1receptors. Eur J Neurosci 2000, 12:533-539. 10.1046/j.1460-9568.2000.00929.x, 10712632.
42. Finn DP, Beckett SR, Roe CH, Madjd A, Fone KC, Kendall DA, Marsden CA, Chapman V. Effects of co-administration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain. Eur J Neurosci 2004, 19:678-686. 10.1111/j.0953-816X.2004.03177.x, 14984418.
43. Ibrahim MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodorova A, Davar G, Makriyannis A, Vanderah TW, Mata HP, Malan TP. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci U S A 2005, 102:3093-3098. 10.1073/pnas.0409888102, 549497, 15705714.
44. Rios C, Gomes I, Devi LA. Mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. Br J Pharmacol 2006, 148:387-395. 1751792, 16682964.
45. Bushlin I, Rozenfeld R, Devi LA. Cannabinoid-opioid interactions during neuropathic pain and analgesia. Curr Opin Pharmacol 2010, 10(1):80-86. 10.1016/j.coph.2009.09.009, 2818338, 19857996.
46. Ibrahim MM, Deng H, Zvonok A, Cockayne DA, Kwan J, Mata HP, Vanderah TW, Lai J, Porreca F, Makriyannis A, JR Malan TP. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci U S A 2003, 100:10529-10533. 10.1073/pnas.1834309100, 193595, 12917492.
47. Luongo L, Palazzo E, de Novellis V, Maione S. Role of Endocannabinoids in Neuron-Glial Crosstalk. The Open Pain Journal 2010, 3:29-36.
48. Racz I, Nadal X, Alferink J, Baños JE, Rehnelt J, Martín M, Pintado B, Gutierrez-Adan A, Sanguino E, Manzanares J, Zimmer A, Maldonado R. Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain. J Neurosci 2008, 28(46):12125-12135. 10.1523/JNEUROSCI.3400-08.2008, 19005077.
49. Zhang FY, Wan Y, Zhang ZK, Light AR, Fu KY. Peripheral formalin injection induces long-lasting increases in cyclooxygenase 1 expression by microglia in the spinal cord. J Pain 2007, 8(2):110-117. 10.1016/j.jpain.2006.06.006, 16949875.
50. Spigelman I. Therapeutic Targeting of Peripheral Cannabinoid Receptors in Inflammatory and Neuropathic Pain States. Translational Pain Research: From Mouse to Man. Boca Raton, Frontiers in Neuroscience 2010 2010, CRC Press, FL, Chapter 5.
51. Torsney C, Fitzgerald M. Age-dependent effects of peripheral inflammation on the electrophysiological properties of neonatal rat dorsal horn neurons. J Neurophysiol 2002, 87:1311-1317.
52. Ren K, Anseloni V, Zou SP, Wade EB, Novikova SI, Ennis M, Traub RJ, Gold MS, Dubner R, Lidow MS. Characterization of basal and re-inflammation-associated long-term alteration in pain responsivity following short-lasting neonatal local inflammatory insult. Pain 2004, 110:588-596. 10.1016/j.pain.2004.04.006, 15288399.
53. Walker JM, Huang SM, Strangman NM, Tsou K, Sañudo-Peña MC. Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci U S A 1999, 96:12198-12203. 10.1073/pnas.96.21.12198, 18435, 10518599.
54. McGaraughty S, Chu KL, Perner RJ, Didomenico S, Kort ME, Kym PR. TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats. Mol Pain 2010, 5:6-14.
55. Telleria-Diaz A, Schmidt M, Kreusch S, Neubert AK, Schache F, Vazquez E, Vanegas H, Schaible HG, Ebersberger A. Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids. Pain 2009, 148:26-35.